wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Isoniazid: Chemistry and Mechanism

Total questions: 83

Worksheet time: 42mins

Name
Class
Date
1.

Which description best identifies isoniazid (INH) chemically?

a)

Ester of pyridine carboxylate

b)

Amide of nicotinic aldehyde

c)

Hydrazide of isonicotinic acid

d)

Ketone of isonicotinamide

2.

What is the functional role of KatG in Mycobacterium tuberculosis with respect to INH?

a)

Blocks INH binding to ribosomes

b)

Activates INH by catalase–peroxidase

c)

Exports INH via efflux transporters

d)

Degrades INH through amidase

3.

INH primarily exhibits which type of activity against Mycobacterium tuberculosis?

a)

Fungicidal in mixed cultures

b)

Bacteriostatic in dormant cells

c)

Bactericidal against active bacilli

d)

Virucidal against co-infections

4.

Which enzyme target is directly inhibited by activated INH to disrupt mycolic acid biosynthesis?

a)

DNA gyrase topoisomerase

b)

Dihydropteroate synthase

c)

RNA polymerase beta subunit

d)

InhA enoyl-ACP reductase

5.

Mycolic acids are important in the mycobacterial cell wall primarily because they

a)

Provide a permeability barrier to hydrophilic solutes

b)

Function as cytosolic signaling hormones

c)

Serve as ribosomal assembly scaffolds

d)

Act as primary energy storage lipids

6.

INH is best described as a prodrug because it

a)

Acts only as a competitive antagonist

b)

Is directly active without modification

c)

Requires enzymatic activation to a reactive species

d)

Needs acid-catalyzed hydrolysis in stomach

7.

The NADH-dependent process affected by INH involves

a)

Methylation of rRNA nucleotides

b)

Phosphorylation of cell wall arabinans

c)

Reduction during fatty acid elongation

d)

Oxidation of peptidoglycan chains

8.

Activated INH interferes with NADH by

a)

Cleaving NADH into AMP and ribose

b)

Forming an acylated NADH adduct

c)

Blocking NADH transport across membrane

d)

Promoting NADH overproduction

9.

Which statement about INH’s spectrum within the host is accurate?

a)

Inactive in intracellular environments

b)

Targets only intracellular latent bacilli

c)

Limited to extracellular bacilli exclusively

d)

Effective against extracellular and intracellular bacilli

10.

What combined regimen is commonly preferred to enhance TB treatment when using INH?

a)

INH with amphotericin

b)

INH with acyclovir

c)

INH with rifampin

d)

INH with vancomycin

11.

What catalytic activities are attributed to KatG that facilitate INH activation?

a)

Protease–peptidase activities

b)

Catalase–peroxidase activities

c)

Lyase–decarboxylase activities

d)

Kinase–phosphatase activities

12.

Blocking InhA by INH ultimately prevents

a)

Conversion of pyruvate to lactate

b)

Replication of circular DNA plasmids

c)

Assembly of ribosomal 50S subunits

d)

Synthesis of long-chain mycolic acids

13.

Which structural modification of isoniazid’s hydrazide most consistently retains antitubercular activity?

a)

N2 substitution with alkyl groups

b)

N1 hydrogen retained without alkyl group

c)

Replacement of pyridine ring with benzene

d)

Conversion to stable hydrazone derivatives

14.

Why were isoniazide hydrazones found unsuitable as therapeutic agents?

a)

They lacked GI absorption entirely

b)

They were unstable in the GI tract

c)

They inhibited NAT2 excessively

d)

They formed insoluble glycine conjugates

15.

Which statement best describes the role of NAT2 in isoniazid metabolism?

a)

Microsomal enzyme hydrolyzing hydrazides

b)

Peroxisomal enzyme producing radicals

c)

Mitochondrial enzyme controlling oxidation

d)

Cytosolic enzyme catalyzing acetylation

16.

Individuals with high NAT2 activity are referred to as:

a)

Slow acetylators prone to toxicity

b)

Rapid acetylators requiring higher doses

c)

Rapid acetylators needing dose adjustment

d)

Intermediate acetylators without risk

17.

Which metabolite formation is most directly linked to hepatotoxicity during isoniazid therapy?

a)

Acetylhydrazine generation

b)

Isonicotinic acid conjugation

c)

N-acetylisoniazid production

d)

Diacetylhydrazide formation

18.

In rapid acetylators, acetylhydrazine tends to be:

a)

Deacetylated back to isoniazid

b)

Oxidized to isonicotinic acid faster

c)

Further acetylated to diacetylhydrazide

d)

Hydrolyzed to hydrazine quickly

19.

Which pathway explains liver protein acylation leading to necrosis?

a)

Acetylhydrazine as CYP450 substrate

b)

Isonicotinic acid glycine conjugation

c)

Hydrazone stabilization in plasma

d)

Direct NAT2 oxidation to radicals

20.

What is the proposed reactive intermediate causing hepatotoxicity from acetylhydrazine?

a)

N1-alkylated isoniazid derivative

b)

Glycine-bound isonicotinic acid

c)

Acetyl cation or radical species

d)

Stable diacetylhydrazide conjugate

21.

Which combination of N-substitutions typically destroys isoniazid activity?

a)

R1 and R2 = H, R3 = alkyl

b)

R1 and R2 = alkyl, R3 = H

c)

Any substitution on N1 hydrogen

d)

No substitution on N2 nitrogen

22.

Which metabolite is commonly detected in urine as a glycine conjugate during isoniazid metabolism?

a)

N-acetylisoniazid after conjugation

b)

Acetylhydrazine after oxidation

c)

Isonicotinic acid after hydrolysis

d)

Hydrazine from hydrazide hydrolysis

23.

Which best describes the core mechanism of rifamycins against tuberculosis bacteria?

a)

Inhibit DNA-dependent RNA polymerase beta-subunit

b)

Disrupt peptidoglycan crosslinking in cell wall

c)

Chelate iron to starve bacteria of nutrients

d)

Block 30S ribosomal decoding during translation

24.

Which statement about the macrocyclic structure of rifamycins is most accurate for activity?

a)

Ring opening generally increases antibacterial potency

b)

Linear analogs penetrate gram-negative cell walls better

c)

Cyclization only improves oral absorption, not activity

d)

Intact macrocycle is required to maintain activity

25.

Which functional groups on rifamycin contribute to binding via hydrogen bonding to DDRP?

a)

Tertiary amines at C12 and C14 sites

b)

Free hydroxyls at C21 and C23 positions

c)

Sulfonamides at C3 and C5 positions

d)

Nitro groups at C7 and C9 positions

26.

Which feature of DDRP supports rifamycin binding through metal coordination?

a)

Possesses calcium-stabilized beta-sheet

b)

Contains two zinc atoms for chelation

c)

Has copper-dependent catalytic residues

d)

Requires magnesium in the active pocket

27.

Which pharmacologic effect is characteristic during rifampin therapy?

a)

Blue urine due to riboflavin excretion

b)

Red-orange discoloration of body fluids

c)

Black stools from iron chelation effects

d)

Green discoloration of sweat and tears

28.

Which statement best distinguishes rifampin’s action on transcription?

a)

Blocks elongation of full-length RNA transcripts

b)

Destroys promoter sequences on bacterial DNA

c)

Inhibits sigma-factor binding to the core enzyme

d)

Prevents ribosome initiation on mRNA templates

29.

A common resistance mechanism to rifamycins in bacteria involves:

a)

Efflux pumps removing drug from cytosol

b)

Altered porin expression in outer membrane

c)

Mutations in DDRP beta-subunit gene

d)

Enzymatic hydrolysis by beta-lactamase

30.

Which SAR statement aligns with rifamycin activity requirements?

a)

Double bond reduction increases intrinsic potency

b)

Free OH groups at C1, C8, C21, C23 are needed

c)

Acylation at C21–C23 enhances binding strength

d)

Substituting C3 and C4 removes antibacterial effects

31.

Which best explains rifampin’s limited utility against some gram-negative infections?

a)

Instability in acidic outer membrane milieu

b)

Rapid metabolism by periplasmic enzymes

c)

Weak binding to gram-negative ribosomes

d)

Poor penetration through gram-negative cell wall

32.

Which metabolic pathway primarily inactivates rifampin?

a)

N-oxidation of hydrazine producing toxic species

b)

Glucuronidation at C3 creating inactive conjugates

c)

Deacetylation at C25 forming active metabolites

d)

O-demethylation at C5 followed by oxidation

33.

Which semisynthetic modification differentiates rifampin from rifapentine?

a)

Variation in R group attached to hydrazone

b)

Presence of extra macrocyclic ether ring

c)

Substitution of beta-lactam side chain

d)

Addition of fluorine at the C7 position

34.

Which statement best describes pyrazinamide’s relationship to nicotinamide?

a)

Prodrug of nicotinamide adenine dinucleotide

b)

Unrelated aliphatic amide compound

c)

Direct inhibitor of nicotinamide transport

d)

Structural bioisostere of nicotinamide

35.

What is the active metabolite generated from pyrazinamide inside mycobacteria?

a)

Isonicotinic acid

b)

Pyrazinoic acid

c)

5‑hydroxypyrazinamide

d)

Nicotinic acid

36.

Which enzyme in mycobacteria hydrolyzes pyrazinamide to its active form?

a)

Xanthine oxidase

b)

Transpeptidase

c)

Arabinosyl transferase

d)

Pyrazinamidase

37.

At what environmental condition does pyrazinoic acid exert notable biological activity around M. tuberculosis?

a)

Alkaline pH above 8.5

b)

Neutral pH around 7.0

c)

Hypoxic pH-independent state

d)

Acidic pH near 5.5

38.

Which mechanism contributes to pyrazinamide’s bactericidal effect against semi‑dormant bacilli?

a)

Direct inhibition of DNA gyrase

b)

Disrupting ribosomal assembly at 50S

c)

Blocking folate synthesis pathway

d)

Intracellular acidification by pyrazinoic acid

39.

A key resistance mechanism to pyrazinamide involves mutation in which gene?

a)

rpoB polymerase gene

b)

pyrazinamidase gene

c)

embCAB operon

d)

katG peroxidase gene

40.

Which pharmacokinetic statement about pyrazinamide is most accurate?

a)

Poor oral absorption, mostly unchanged excreted

b)

Readily absorbed orally, little unchanged excreted

c)

Parenteral only, minimal systemic absorption

d)

Extensive renal secretion of intact drug

41.

Which hepatic process converts pyrazinamide to pyrazinoic acid in humans?

a)

Peroxisomal deamination

b)

Microsomal hydrolysis

c)

Cytosolic methylation

d)

Mitochondrial oxidation

42.

Introducing pyrazinamide into combination TB therapy primarily achieves which clinical outcome?

a)

Reduces hepatotoxicity risk

b)

Eliminates need for ethambutol

c)

Increases monotherapy success

d)

Shortens regimen duration

43.

Why is pyrazinamide included in combination therapy from a resistance standpoint?

a)

It slows resistance development

b)

It reverses existing resistance

c)

It avoids all cross‑resistance

d)

It selects for hyper‑susceptible mutants

44.

Ethambutol’s mechanism primarily targets which biosynthetic process in mycobacteria?

a)

Cell wall synthesis

b)

Mycolic acid beta‑oxidation

c)

Protein translation

d)

DNA replication

45.

Ethambutol inhibits which enzyme family essential for arabinan polymer assembly?

a)

Arabinosyl transferases

b)

Transpeptidases

c)

Beta‑lactamases

d)

Topoisomerases

46.

Which mycobacterial cell wall components are impacted by ethambutol’s inhibition of arabinan synthesis?

a)

Lipopolysaccharide and porins

b)

Peptidoglycan and teichoic acids

c)

Capsular polysaccharides only

d)

Arabinogalactan and lipoarabinomannan

47.

Which structural feature is central to ethambutol’s SAR for activity?

a)

Macrolide lactone ring

b)

Ethylene diamine chain

c)

Aromatic pyridine ring

d)

Sulfonamide linkage

48.

Which ribosomal target is primarily affected by streptomycin in Mycobacterium tuberculosis?

a)

70S initiation complex

b)

50S subunit binding site

c)

30S subunit decoding site

d)

23S rRNA peptidyl center

49.

Streptomycin’s action includes which additional effect beyond inhibiting protein synthesis?

a)

DNA strand breaks induction

b)

mRNA misreading and membrane damage

c)

tRNA charging inhibition

d)

Cell wall arabinan blockade

50.

Adenylyltransferase-mediated modification of streptomycin produces which inactive form?

a)

O-6 adenylate derivative

b)

N-1 adenylate conjugate

c)

O-3 adenylate metabolite

d)

C-2 adenylate product

51.

Phosphotransferase inactivation of streptomycin typically yields which product?

a)

C-5 phosphate addition

b)

O-1 phosphorylate analogue

c)

N-6 phosphate ester

d)

O-3 phosphorylate metabolite

52.

Why do chemically modified streptomycin metabolites fail to bind ribosomes?

a)

Loss of positive charge only

b)

Enhanced efflux pump recognition

c)

Steric hindrance at decoding site

d)

Reduced hydrophobic interactions

53.

Dihydrostreptomycin compared with streptomycin is noted for which clinical concern?

a)

Greater potential for delayed deafness

b)

Higher nephrotoxicity risk

c)

More severe hypersensitivity rates

d)

Lower antibacterial spectrum

54.

Oxidation of the aldehyde of streptomycin to a carboxylic group results in what?

a)

Inactive analogue formation

b)

Enhanced ribosomal binding

c)

Improved tissue penetration

d)

Prolonged serum half-life

55.

Modification of the methyl group in L-streptose to methylene-hydroxyl yields an analogue with what property?

a)

Superior activity against M. leprae

b)

Selectively targets 50S subunit

c)

Inactive due to poor uptake

d)

Active but no advantage over streptomycin

56.

Alkyl changes to the amino-methyl group on the glucosamine moiety of streptomycin typically do what?

a)

Guarantee resistance reversal

b)

Enhance carboxylate formation

c)

Remove activity by guanidine deletion

d)

Increase activity with higher alkyl groups

57.

Which list best represents common second-line agents for TB?

a)

Ethionamide, PAS, cycloserine, capreomycin, kanamycin

b)

Isoniazid, rifampin, pyrazinamide, ethambutol

c)

Streptomycin, amikacin, gentamicin, tobramycin

d)

Levofloxacin, moxifloxacin, linezolid, bedaquiline

58.

Second-line TB agents are usually reserved for which situation?

a)

Latent TB prophylaxis solely

b)

Initial induction therapy always

c)

Exclusive use in pediatric TB

d)

First-line intolerance or resistance cases

59.

Ethionamide is best described as which structural relationship?

a)

Fluoroquinolone mimic

b)

Prodrug of ethambutol

c)

Derivative of streptidine

d)

Analog of isonicotinamide

60.

Replacing ethionamide’s ethyl group with propyl gives what agent?

a)

Cycloserine

b)

Protionamide

c)

Kanamycin

d)

Capreomycin

61.

Ethionamide is bactericidal against which organisms?

a)

S. aureus and P. aeruginosa

b)

C. difficile and E. coli

c)

M. kansasii and M. avium

d)

M. tuberculosis and M. leprae

62.

Which statement best explains ethionamide’s mechanism of action?

a)

Direct inhibition of 30S ribosome

b)

Chelation of Mg2+ to disrupt ATP synthase

c)

Activation to sulfoxide that acylates and inactivates InhA enoyl reductase

d)

Binding arabinosyl transferase to block arabinan

63.

Which enzyme system is involved in converting ethionamide to its active form?

a)

Catalase–peroxidase mediated oxidation

b)

Beta-lactamase cleavage reaction

c)

P450 monooxygenase hydroxylation

d)

Glutathione S-transferase conjugation

64.

Which statement best describes para-aminosalicylic acid (PAS) in tuberculosis therapy?

a)

Chelates iron to disrupt heme synthesis

b)

Blocks ATP synthase in bacterial membranes

c)

Acts as a folate antimetabolite resembling PABA

d)

Directly inhibits DNA gyrase in mycobacteria

65.

PAS co-administered with isoniazid is valuable in rapid acetylators because it

a)

Enhances rifampicin activation by hepatic enzymes

b)

Prevents renal excretion of pyrazinamide metabolites

c)

Reduces acetylation of isoniazid by competing as substrate

d)

Increases gastric absorption of ethionamide significantly

66.

A likely adverse effect of PAS at therapeutic doses is

a)

Gastrointestinal irritation with hypersensitivity risk

b)

Bronchospasm as a common acute reaction

c)

Ototoxicity with irreversible hearing loss

d)

Severe hemolysis due to G6PD deficiency

67.

Cycloserine’s primary pharmacologic target in mycobacteria involves inhibition of

a)

D-alanine racemase and D-alanine ligase enzymes

b)

Protein synthesis at the 30S ribosomal subunit

c)

Topoisomerase IV and DNA gyrase enzymes

d)

Transcription by blocking RNA polymerase

68.

Why is D-alanine critical for mycobacterial cell wall integrity?

a)

It regulates synthesis of lipoarabinomannan lipids

b)

It forms the D-alanine–D-alanine dipeptide for peptidoglycan

c)

It donates electrons in respiratory chain complexes

d)

It cross-links arabinogalactan to mycolic acids

69.

Cycloserine is considered a rigid analog of D-alanine. This structural relationship allows it to

a)

Competitively block binding of D-alanine to target enzymes

b)

Irreversibly alkylate cysteine residues in enzyme active sites

c)

Stimulate efflux pumps that expel cell wall precursors

d)

Disrupt membrane potential by acting as an ionophore

70.

Which sequence correctly outlines the role of D-alanine in peptidoglycan biosynthesis?

a)

Phosphorylation by kinases, polymerization to polyalanine, membrane insertion

b)

Condensation to dihydrodipicolinate, reduction to lysine, cross-linking step

c)

Decarboxylation of pyruvate, transamination to L-alanine, lipid II transport

d)

Racemization of L-alanine to D-alanine, formation of D-Ala–D-Ala, incorporation into cell wall

71.

A patient on cycloserine develops reduced peptidoglycan synthesis. The most proximal biochemical explanation is

a)

Inhibited conversion of L-alanine to D-alanine

b)

Impaired proton motive force across the membrane

c)

Blocked synthesis of mycolic acids from fatty acids

d)

Reduced activity of RNA polymerase sigma factor

72.

PAS metabolism involves which processes at functional groups?

a)

Acetylation of the amino group with conjugation at carboxyl group

b)

Sulfation of the phenolic ring with oxidative deamination

c)

Phosphorylation of the carboxylate with glycine cleavage

d)

Glucuronidation of the amide nitrogen with methylation

73.

In designing combination therapy for TB, cycloserine’s mechanism complements PAS because

a)

Both inhibit the same enzyme increasing potency synergistically

b)

Each amplifies ethionamide toxicity through shared metabolism

c)

One inhibits cell wall synthesis while the other disrupts folate pathway

d)

They jointly block ATP synthase leading to bactericidal action

74.

What is the primary rationale for using combination therapy in tuberculosis treatment?

a)

To avoid drug interactions between agents

b)

To minimize costs by using fewer agents

c)

To increase patient adherence to single drug

d)

To reduce emergence of drug resistance strains

75.

Which factor should guide the choice of antitubercular agents for a patient?

a)

Hospital bed availability and cost

b)

Patient’s preference for oral therapy

c)

Seasonal prevalence of tuberculosis

d)

Location of disease and patient condition

76.

Which three drugs constitute a commonly recommended initial 8‑week TB regimen?

a)

Isoniazid, rifampin, pyrazinamide

b)

Ethambutol, streptomycin, kanamycin

c)

Isoniazid, kanamycin, capreomycin

d)

Rifampin, capreomycin, pyrazinamide

77.

Adding pyrazinamide to INH and rifampin primarily leads to which outcome?

a)

Shortening total treatment duration

b)

Increasing hepatotoxicity without benefit

c)

Preventing peripheral neuropathy

d)

Eliminating need for susceptibility testing

78.

In areas with high incidence of drug resistance, which modification is appropriate for initial therapy?

a)

Reduce treatment duration to 12 weeks

b)

Avoid pyrazinamide during induction

c)

Use monotherapy with rifampin

d)

Include ethambutol in the regimen

79.

Which statement reflects a cardinal rule for TB regimens?

a)

Delay susceptibility testing for weeks

b)

Start with one highly effective drug

c)

Begin therapy with at least three drugs

d)

Never add drugs to a failing regimen

80.

What is the proven prophylaxis for tuberculosis and typical duration?

a)

INH for 6–12 months

b)

RIF for 2–4 weeks

c)

PZA for 3–5 months

d)

EMB for 1–2 months

81.

Which patients are considered high risk warranting prophylaxis?

a)

Young adults without exposure

b)

Individuals with normal radiographs

c)

HIV infection and close contacts

d)

Patients with healed fractures

82.

Which adverse effect is most concerning during long‑term INH therapy?

a)

Severe liver damage and hepatitis

b)

Irreversible ototoxicity and deafness

c)

Profound hypoglycemia and coma

d)

Acute renal failure and stones

83.

How can INH‑related peripheral neuropathy be prevented?

a)

Avoiding pyrazinamide completely

b)

Adding capreomycin weekly

c)

Dose reduction of rifampin

d)

Co‑administration of pyridoxine